Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic-Associated Fatty Liver Disease (MAFLD), Diabetes, and Cardiovascular Disease: Associations with Fructose Metabolism and Gut Microbiota
Authors
Keywords
-
Journal
Nutrients
Volume 14, Issue 1, Pages 103
Publisher
MDPI AG
Online
2021-12-28
DOI
10.3390/nu14010103
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microbiota analysis and transient elastography reveal new extra-hepatic components of liver steatosis and fibrosis in obese patients
- (2021) Nicolas Lanthier et al. Scientific Reports
- Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact
- (2021) Alfredo Caturano et al. Processes
- Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
- (2021) Alessandro Mantovani et al. Metabolites
- Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis
- (2021) Fuxi Li et al. Lipids in Health and Disease
- Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
- (2021) Luca Rinaldi et al. Antioxidants
- Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes
- (2021) Ferdinando Carlo Sasso et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
- (2021) Tiantian Song et al. Diabetes Therapy
- Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes： A Network Meta-Analysis
- (2021) Jingxuan Lian et al. Frontiers in Endocrinology
- Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort
- (2021) Tracey G Simon et al. GUT
- Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed
- (2021) Christopher D Byrne et al. GUT
- Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
- (2021) Katsutoshi Tokushige et al. JOURNAL OF GASTROENTEROLOGY
- The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms
- (2021) Teresa Salvatore et al. Frontiers in Medicine
- Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials
- (2021) Cheng Han Ng et al. Endocrine Practice
- A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D)
- (2021) Samit Ghosal et al. Scientific Reports
- Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Peripheral Diabetic Polyneuropathy: A Systematic Review and Meta-Analysis
- (2021) Carla Greco et al. Journal of Clinical Medicine
- Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study
- (2020) Luigi Elio Adinolfi et al. ATHEROSCLEROSIS
- Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of Nonalcoholic Fatty Liver Disease
- (2020) James M. Paik et al. HEPATOLOGY
- Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability
- (2020) Laura Craven et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
- (2020) Mark L. Hartman et al. DIABETES CARE
- NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications
- (2020) Giovanni Targher et al. GUT
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’
- (2020) Yasser Fouad et al. LIVER INTERNATIONAL
- Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
- (2020) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2020) Xiongfeng Pan et al. Scientific Reports
- Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
- (2020) Hyeok-Hee Lee et al. Cardiovascular Diabetology
- Association of Hepatic Steatosis with Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease
- (2020) Nandini M. Meyersohn et al. Clinical Gastroenterology and Hepatology
- Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antivirals therapy. A prospective study.
- (2020) Luigi E Adinolfi et al. DIABETES OBESITY & METABOLISM
- Criteria to Qualify Microorganisms as “Probiotic” in Foods and Dietary Supplements
- (2020) Sylvie Binda et al. Frontiers in Microbiology
- Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)
- (2020) Mohammad S. Kuchay et al. DIABETOLOGIA
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- (2020) Alessandro Mantovani et al. GUT
- Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
- (2020) Hokyou Lee et al. Clinical Gastroenterology and Hepatology
- Organismal Fructose Metabolism in Health and Non-Alcoholic Fatty Liver Disease
- (2020) Shea Skenderian et al. Biology-Basel
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of dapagliflozin, an SGLT2 inhibitor, on serum levels of soluble dipeptidyl peptidase-4 in patients with type 2 diabetes and non-alcoholic fatty liver disease
- (2019) Yoshimasa Aso et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus
- (2019) Hyo Jung Cho et al. Gut and Liver
- Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver?
- (2019) Tien S Dong et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease – a systematic review and meta-analysis
- (2019) Muhammad Y. Khan et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus
- (2019) Lee-Lee Lai et al. DIGESTIVE DISEASES AND SCIENCES
- Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
- (2019) Raul D. Santos et al. ATHEROSCLEROSIS
- Gut microbiome–targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression
- (2019) Suzanne R Sharpton et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Outcomes of Liver Transplantation for Non-alcoholic Steatohepatitis: a European Liver Transplant Registry Study
- (2019) Debashis Haldar et al. JOURNAL OF HEPATOLOGY
- Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes
- (2019) Mohsen Afarideh et al. Primary Care Diabetes
- Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?
- (2019) Judith Aron-Wisnewsky et al. Current Diabetes Reports
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Consumption of Sugar-Sweetened Beverages Has a Dose-Dependent Effect on the Risk of Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Dose-Response Meta-Analysis
- (2019) Hongwei Chen et al. International Journal of Environmental Research and Public Health
- Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients
- (2019) Congxiang Shao et al. DIGESTIVE DISEASES AND SCIENCES
- The gut-liver axis in liver disease: pathophysiological basis for therapy
- (2019) Agustín Albillos et al. JOURNAL OF HEPATOLOGY
- Are Lifestyle Therapies Effective for NAFLD Treatment?
- (2019) Nermeen N. El-Agroudy et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- The Impact of NAFLD and Waist Circumference Changes on Diabetes Development in Prediabetes Subjects
- (2019) Jiwoo Lee et al. Scientific Reports
- Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
- (2019) Myriam Alexander et al. BMJ-British Medical Journal
- Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives
- (2019) Haiming Hu et al. JOURNAL OF GASTROENTEROLOGY
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances
- (2018) Mazen Noureddin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
- (2018) Alessandro Mantovani et al. DIABETES CARE
- Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
- (2018) Mohammad Shafi Kuchay et al. DIABETES CARE
- Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programme
- (2018) K. Cusi et al. DIABETIC MEDICINE
- Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease
- (2018) Yao-Yao Zhou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
- (2018) Thomas Jensen et al. JOURNAL OF HEPATOLOGY
- Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
- (2018) Farnush Bakhshimoghaddam et al. JOURNAL OF NUTRITION
- OUP accepted manuscript
- (2018) NUTRITION REVIEWS
- Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance
- (2018) Hannah E. Da Silva et al. Scientific Reports
- Evaluation of the effects of dapagliflozin, an SGLT2 inhibitor, on hepatic steatosis and fibrosis by transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease
- (2018) Masanori Shimizu et al. DIABETES OBESITY & METABOLISM
- A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?
- (2018) Amedeo Lonardo et al. ACTA DIABETOLOGICA
- Mouse models of nonalcoholic steatohepatitis Towards optimization of their relevance to human NASH
- (2018) Geoff Farrell et al. HEPATOLOGY
- Liraglutide, sitagliptin and insulin glargine added to metformin: the effect on body weight and intrahepatic lipid in patients with type 2 diabetes mellitus and NAFLD
- (2018) Jinhua Yan et al. HEPATOLOGY
- Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals
- (2017) Bo Kobberø Lauridsen et al. EUROPEAN HEART JOURNAL
- Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease
- (2017) Feng Shen et al. Hepatobiliary & Pancreatic Diseases International
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes
- (2017) Yaowu Zou et al. INTERNAL MEDICINE JOURNAL
- Non-alcoholic fatty liver disease is associated with late but not early atherosclerotic lesions in Chinese inpatients with type 2 diabetes
- (2017) Kaifeng Guo et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Emmanuela Gakidou et al. LANCET
- Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease
- (2017) Hashimoto Yoshitaka et al. MEDICINE
- Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism
- (2017) Prasanthi Jegatheesan et al. Nutrients
- Effects of Probiotics, Prebiotics, and Synbiotics on Human Health
- (2017) et al. Nutrients
- Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis
- (2017) Chien-Chao Chiu et al. Nutrients
- Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease
- (2017) Wenhuan Feng et al. Journal of Diabetes
- Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease
- (2017) Jessica Lambertz et al. Frontiers in Immunology
- Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage
- (2017) Mario Masarone et al. PLoS One
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Non-alcoholic fatty liver disease and risk of type 2 diabetes
- (2016) S. Lallukka et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Noninvasive fatty liver markers predict liver disease mortality in the U.S. population
- (2016) Aynur Unalp-Arida et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus
- (2016) Yuya Seko et al. HEPATOLOGY RESEARCH
- Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
- (2016) Stefano Ballestri et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis
- (2016) Matthew J. Armstrong et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
- (2016) Sven M. Francque et al. JOURNAL OF HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
- (2016) Luca Valenti et al. LIVER INTERNATIONAL
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications
- (2016) Li-hui Yan et al. Journal of Diabetes Investigation
- Soft Drink Consumption Linked with Fatty Liver in the Absence of Traditional Risk Factors
- (2016) Nimer Assy et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- The Relationship between Nonalcoholic Fatty Liver Disease and Retinopathy in NHANES III
- (2016) Tzu-Yu Lin et al. PLoS One
- Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
- (2016) Shunquan Wu et al. Scientific Reports
- Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease
- (2016) Baohong Wang et al. Scientific Reports
- Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease
- (2015) A. Wieland et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- How informative is the mouse for human gut microbiota research?
- (2015) T. L. A. Nguyen et al. Disease Models & Mechanisms
- Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study
- (2015) Ali A Rizvi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
- (2015) Robert J. Wong et al. GASTROENTEROLOGY
- Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
- (2015) Raymond Kwok et al. GUT
- Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat
- (2015) Jean-Marc Schwarz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts
- (2015) Jiantao Ma et al. JOURNAL OF HEPATOLOGY
- Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study
- (2015) Jessica L. Mellinger et al. JOURNAL OF HEPATOLOGY
- Associations of sugar- and artificially sweetened soda with nonalcoholic fatty liver disease: a systematic review and meta-analysis
- (2015) K. Wijarnpreecha et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Review article: next generation diagnostic modalities in gastroenterology - gas phase volatile compound biomarker detection
- (2014) R. P. Arasaradnam et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis
- (2014) Mei Chung et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study
- (2014) Tannaz Eslamparast et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials
- (2014) S Chiu et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)
- (2014) Yuichiro Eguchi et al. HEPATOLOGY RESEARCH
- Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes
- (2014) Yongqiang Li et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Nonalcoholic Fatty Liver Disease Is Associated With Increased Carotid Intima-Media Thickness Only in Type 2 Diabetic Subjects With Insulin Resistance
- (2014) Soo-Kyung Kim et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sugar-Sweetened Beverages With Moderate Amounts of Fructose, but Not Sucrose, Induce Fatty Acid Synthesis in Healthy Young Men: A Randomized Crossover Study
- (2014) Michel Hochuli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dietary Fructose Reduction Improves Markers of Cardiovascular Disease Risk in Hispanic-American Adolescents with NAFLD
- (2014) Ran Jin et al. Nutrients
- Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: A computed tomography angiography study 在2型糖尿病患者中非酒精性脂肪性肝病与严重冠心病有关：一项计算机断层扫描血管造影研究
- (2014) Ilkay S. Idilman et al. Journal of Diabetes
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2014) Giovanni Musso et al. PLOS MEDICINE
- Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease
- (2013) Maitreyi Raman et al. Clinical Gastroenterology and Hepatology
- Gut microbiota and non-alcoholic fatty liver disease: new insights
- (2013) J. Aron-Wisnewsky et al. CLINICAL MICROBIOLOGY AND INFECTION
- Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.
- (2013) Robert J. Wong et al. HEPATOLOGY
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
- (2013) V. K. Ridaura et al. SCIENCE
- Effects of probiotics on nonalcoholic fatty liver disease: A meta-analysis
- (2013) Yan-Yan Ma WORLD JOURNAL OF GASTROENTEROLOGY
- Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population
- (2012) Maria Stepanova et al. Clinical Gastroenterology and Hepatology
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
- (2012) Jorge Henao-Mejia et al. NATURE
- Meta-analysis: pioglitazone improves liver histology and fibrosis in patients with non-alcoholic steatohepatitis
- (2011) E. Boettcher et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study
- (2011) Maria Maersk et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Pioglitazone in the treatment of NASH: the role of adiponectin
- (2010) A. Gastaldelli et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease
- (2010) Manal F. Abdelmalek et al. HEPATOLOGY
- FAO Technical Meeting on Prebiotics
- (2010) Maya Pineiro et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- A position statement on NAFLD/NASH based on the EASL 2009 special conference
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
- (2010) Jung Sub Lim et al. Nature Reviews Gastroenterology & Hepatology
- Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver
- (2009) Laura G. Sánchez-Lozada et al. EUROPEAN JOURNAL OF NUTRITION
- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
- (2009) Kittichai Promrat et al. HEPATOLOGY
- Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
- (2009) Kimber L. Stanhope et al. JOURNAL OF CLINICAL INVESTIGATION
- Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome
- (2009) Ali Abid et al. JOURNAL OF HEPATOLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Increased Risk of CKD among Type 2 Diabetics with Nonalcoholic Fatty Liver Disease
- (2008) G. Targher et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started